The "Regenerative Medicine Collaboration and Licensing Deals 2019-2025" has been added to ResearchAndMarkets.com's offering.This report contains a comprehensive listing of 1390 regenerative medicine ...

Lead product GelrinC®, a hydrogel synchronized erosion and resorbable implant, the only restorative product for knee ...

São Paulo continues its internal restructuring process for the 2026 season, following a terrible year, especially in its ...

The Global Bio Preservation Market presents growth opportunities driven by the rising demand for organ transplants and ...

The NCAA must still formally approve the rule change, but it is expected to pass, with a dealmaking frenzy to follow.

Type 1 diabetes (T1D) is an autoimmune disorder characterized by the specific destruction of insulin-producing pancreatic β-cells.

Orthopedic regenerative medicine evolves with multicenter efforts to customize orthobiologic treatments and improve patient outcomes by 2026.

March Bio is continuing enrollment in the Phase 2 trial, with the Independent Data Monitoring Committee’s approval to advance to Simon Stage 2 of the Phase 2 trial. The Company anticipates presenting ...

Regenerative medicine has emerged as one of the most dynamic fields of modern biomedical research, and stem cells continue to ...

Researchers have found scientific support for the viral claim that rosemary can improve wound healing. Carnosic acid, a natural antioxidant in rosemary, promoted scar-free healing in mice by ...

The nanopharmaceuticals market presents opportunities in addressing chronic diseases through enhanced targeted therapies and ...